Brain tissue damage therapies

Details Brain tissue damage therapies Brain tissue damage therapies

2011-04-12

2011-04-12

Bertoglio, Valarie (Department: 1632)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Animal or plant cell

C424S093210, C424S093100, C435S372000

Reexamination Certificate

active

07923007

ABSTRACT:
A cultured pluripotent animal cell that is CD13+, CD90+, and CD117−. Also disclosed are methods for making the cell and methods of treating a brain tissue damage and increasing the expression level of a neuraltrophic factor in a subject.

REFERENCES:
patent: 2002/0028510 (2002-03-01), Sanberg et al.
patent: 2004/0136967 (2004-07-01), Weiss et al.
Yang , Springer Semin. Immun., 26: 187-200, 2004.
Kozlowska et al (2007, Stem Cells and Development, 16:481-488.
Weiss, 2003, Experimental Neurology, 182:288-299.
Lu et al., 2002, Cell Transplantation, 11:275-281.
Chen et al., 2001, Stroke, 32:1005-1011.
Rojewski, 2008, Tranfus Med Hemother, 35:168-184.
Fink, JS et al, 2000; Cell Transplantation, 9:273-278.
Mitchell et al., “Matrix Cells from Wharton's Jelly Form Neurons and Glia,”Stem Cells, 21:50-60 (2003).
Wang et al., “Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical Cord,”Stem Cells, 22:1330-1337 (2004).
Zhao et al., “Human Bone Marrow Stem Cells Exhibit Neural Phenotypes and Ameliorate Neurological Deficits after Grafting into the Ischemic Brain of Rats,”Experimental Neurology, 174:11-20 (2002).

Affiliated with

Also associated with

Rating

Brain tissue damage therapies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Brain tissue damage therapies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Brain tissue damage therapies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2714852